1. C.f. K. Takahashi: Chem. Rev. 98, 2013 (1998)
2. (a) K.-H. Frömming and J. Szejtli: Cyclodextrins in Pharmacy, Kluwer Academic Publishers (1994);
3. (b) T. Nagai and H. Ueda: Aspects of Drug Formulation with Cyclodextrins. In, J.-M. Lehn, J.L. Atwood, J.E.D. Davies, D.D. McNicol, and F. Vögtle (eds.), Comprehensive Supramolecular Chemistry, Pergamon, New York (1996), Vol. 3, J. Szejtli and T. Osa (volume eds.), pp. 441–450;
4. (c) K. Uekama and T. Irie: Pharmaceutical Use of Cyclodextrins in Various Drug Formulations, ibid. pp. 451–482;
5. (d) Proceedings of the 11th International Cyclodextrin Symposium, Reykjavik 2002, Iceland: J. Incl. Phenom. 44(1–4), 3–457 (2002);